Journals / Turkish Journal of Chemistry / 2020 / Cilt: 44 - Sayı: 4

In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives

Pages
1068–1084
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It can be concluded that the synthesized compound could be used as a lead molecule in the development of new antibacterial agents with high efficacy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the present work, a library of fifteen 2-hydroxy benzothiazole-linked 1,3,4 -oxadiazole derivatives have been synthesized and confirmed using different analytical techniques.
📊
Key Findings & Data:From the ADME predictions, compound 4 showed the highest in silico absorption percentage (86.77%), while most of the compounds showed more than 70% absorption.
💡
Conclusion & Impact:It can be concluded that the synthesized compound could be used as a lead molecule in the development of new antibacterial agents with high efficacy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In the present work, a library of fifteen 2-hydroxy benzothiazole-linked 1,3,4 -oxadiazole derivatives have been synthesized and confirmed using different analytical techniques. All of the synthesized compounds have been tested for antibacterial and in silico pharmacokinetic studies for the first time. From the ADME predictions, compound 4 showed the highest in silico absorption percentage (86.77%), while most of the compounds showed more than 70% absorption. All of the compounds comply with the Lipinski rule of 5, suggesting that the compounds possess good drug likeness properties upon administration. Furthermore, all of the compounds follow the Veber rule, indicating good bioavailability and good intestinal absorption. The antibacterial results exhibited excellent to moderate activity. Compounds 5, 9, 12, 14, 15, 16, and 17 were the most active compounds against the tested bacterial strains. Compound 14 showed comparable MIC 6.25 ±0.2 µg/disc to the standard drug amoxicillin against the tested Gram-positive bacterial strains. Compounds 5, 14, 17 exhibited MIC 12.5 ±0.8 µg/disc, which was comparable to the standard drug against E. faecalis. It can be concluded that the synthesized compound could be used as a lead molecule in the development of new antibacterial agents with high efficacy.

🔖

Cite This Article

ALGHAMDI, A. A., ALAM, M. M., NAZREEN, S. (2022). In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives. Turkish Journal of Chemistry, Cilt: 44 - Sayı: 4, 1068–1084. https://ajindex.com/articles/601611

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Kamal A, Hussaini SMA, Faazil S, Poornachandra Y, Narendra RG et al. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5 -nitrofuran based 1,2,3 -triazoles. Bioorganic and Medicinal Chemistry Letters 2013
  2. 23 (24): 68426846. doi: 10.1016/j.bmcl.2013.10.010 2. Upmanyu N, Kumar S, Shah K, Mishra P. Synthesis and antimicrobial studies of some 4 -(substituted)-ethanoylamino3 -mercapto- 5 - (4 - substituted) phenyl-1,2,4 -triazoles. Dhaka University Journal of Pharmaceutical Sciences 2012
  3. 11 (1): 718. doi:10.3329/dujps.v11i1.12481 3. Kamal A, Hussaini SMA, Mohammed SM.Therapeutic potential of benzothiazoles: a patent review (2010-2014). Expert Opinion on Therapeutic Patents 2015
  4. 25 (3): 335349. doi: 10.1517/13543776.2014.999764 4. Koci J, Klimesova V, Waisser K, Kaustova J, Dahse HM et al. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity. Bioorganic and Medicinal Chemistry Letters 2002
  5. 12 (22): 32753278. doi: 10.1016/S0960- 894X(02)00697-2 5. Patel NB, Shaikh FM. Synthesis and antimicrobial activity of new 4 -thiazolidinone derivatives containing 2-amino6 methoxy benzothiazole. Saudi Pharmaceutical Journal 2010
  6. 18 (3): 129136. doi: 10.1016/j.jsps.2010.05.002 6. Patel RV, Park SW. Catalytic N-formylation for synthesis of 6-substituted-2-benzothiazolylimino-5 -piperazinyl- 4- thiazolidinone antimicrobial agents. Research on Chemical Intermediates 2015
  7. 41 (8): 55995609. doi: 10.1007/s11164- 014-1684-8 7. Huang ST, Hsei IJ, Chen C. Synthesis and anticancer evaluation of bis (-benzimidazoles), bis (benzoxazoles), and benzothiazoles. Bioorganic and Medicinal Chemistry 2006
  8. 14 (17): 61066119. doi: 10.1016/j.bmc.2006.05.007 8. Van Zandt MC, Jones ML, Gunn DE, Geraci LS, Jones JH et al. Discovery of 3-[(4,5,7-trifluorobenzothiazol2-yl)methyl]indole-N-acetic acid (Lidorestat) and congeners as highly potent and selective ınhibitors of aldose reductase for treatment of chronic diabetic complications. Journal of Medicinal Chemistry 2005
  9. 48 (9): 31413152. doi: 10.1021/jm0492094 9. Nagarajan SR, Crescenzo GAD, Getman DP, Lu HF, Sikorski JA et al. Discovery of novel benzothiazole sulfonamides as potent inhibitors of HIV-1 protease. Bioorganic and Medicinal Chemistry 2003
  10. 11 (22): 47694777. doi: 10.1016/j.bmc.2003.07.001 10. Takasu K, Inoue H, Kim H, Suzuki M, Shishido T et al. Rhodacyanine dyes as antimalarials. 1. preliminary evaluation of their activity and toxicity. Journal of Medicinal Chemistry 20